Detalles de la búsqueda
1.
[Analysis of verification results of protective effects of hearing protectors in different industries].
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi;
41(5): 333-337, 2023 May 20.
Artículo
en Zh
| MEDLINE | ID: mdl-37248077
2.
[Risk assessment on noise-induced hearing loss of 488 workers in a petrochemical plant].
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi;
40(12): 893-897, 2022 Dec 20.
Artículo
en Zh
| MEDLINE | ID: mdl-36646479
3.
Elevated expression of CDT1 in childhood acute lymphoblastic leukemia promotes cell proliferation, invasion and migration through activation of EMT.
J Biol Regul Homeost Agents;
35(Special Issue on Internal Medicine n.1)2021 07 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-34348833
4.
[Relationship between insulin resistance, serum VCAM-1, FGF19, IGF-1 and colorectal polyps].
Zhonghua Zhong Liu Za Zhi;
43(5): 553-562, 2021 May 23.
Artículo
en Zh
| MEDLINE | ID: mdl-34034475
5.
[Characteristics of esophageal motility and clinical presentation in gastroesophageal reflux disease patients of different age groups].
Zhonghua Yi Xue Za Zhi;
101(14): 1015-1019, 2021 Apr 13.
Artículo
en Zh
| MEDLINE | ID: mdl-33845540
6.
[Effect of perioperative accelerated rehabilitation management program for children with congenital spinal deformity].
Zhonghua Yi Xue Za Zhi;
101(45): 3730-3735, 2021 Dec 07.
Artículo
en Zh
| MEDLINE | ID: mdl-34856701
7.
[Prevalence of diabetes and its associated factors in Blang ethnic adults].
Zhonghua Nei Ke Za Zhi;
58(1): 27-32, 2019 Jan 01.
Artículo
en Zh
| MEDLINE | ID: mdl-30605947
8.
[A comparison of efficacy and safety between Chinese generic imatinib versus branded imatinib in patients with newly-diagnosed chronic myeloid leukemia in the chronic phase: a single-center prospective cohort study].
Zhonghua Nei Ke Za Zhi;
55(12): 922-926, 2016 Dec 01.
Artículo
en Zh
| MEDLINE | ID: mdl-27916045
9.
Relationship between pulmonary function changes and chronic cough in children with cough variant asthma.
J Biol Regul Homeost Agents;
34(5): 1745-1748, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33161697
10.
[Factors influencing severe cytopenia in chronic phase chronic myeloid leukemia patients receiving initial second generation tyrosine kinase inhibitors and its impact on treatment responses and outcomes].
Zhonghua Xue Ye Xue Za Zhi;
44(4): 295-301, 2023 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-37356998
11.
[Clinical and genetic characteristics of young patients with myeloproliferative neoplasms].
Zhonghua Xue Ye Xue Za Zhi;
44(3): 193-201, 2023 Mar 14.
Artículo
en Zh
| MEDLINE | ID: mdl-37356980
12.
[Combination of socio-demographic and clinical co-variates for predicting treatment responses and outcomes in patients with chronic myeloid leukemia in the chronic phase].
Zhonghua Xue Ye Xue Za Zhi;
43(1): 54-62, 2022 Jan 14.
Artículo
en Zh
| MEDLINE | ID: mdl-35231994
13.
[The efficacy and safety of low-dose chemotherapy combined with tyrosine kinase inhibitors in the treatment of Philadelphia-chromosomal-positive acute lymphoblastic leukemia].
Zhonghua Xue Ye Xue Za Zhi;
43(7): 550-556, 2022 Jul 14.
Artículo
en Zh
| MEDLINE | ID: mdl-36709131
14.
[Clinical characteristics, treatment pattern, and outcomes in newly diagnosed patients with chronic myeloid leukemia in the chronic phase by age].
Zhonghua Xue Ye Xue Za Zhi;
42(2): 101-108, 2021 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-33858039
15.
[Health-related quality of life and its associated variables in Chinese patients with Philadelphia-negative myeloproliferative neoplasms].
Zhonghua Xue Ye Xue Za Zhi;
42(12): 985-992, 2021 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-35045668
16.
[Dasatinib-related pulmonary adverse events in patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi;
41(12): 1013-1019, 2020 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-33445849
17.
[Variables associated with BCR-ABL kinase domain mutation in TKI-resistant patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi;
41(6): 469-476, 2020 Jun 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32654459
18.
[Analysis of the efficacy and influencing factors of nilotinib or dasatinib as second- or third-line treatment in patients with chronic myeloid leukemia in the chronic phase and accelerated phase].
Zhonghua Xue Ye Xue Za Zhi;
41(2): 93-99, 2020 Feb 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32135623
19.
[Severe hematologic toxicity and its impact on treatment response in newly diagnosed patients with chronic myeloid leukemia receiving tyrosine kinase-inhibitor therapy].
Zhonghua Xue Ye Xue Za Zhi;
40(4): 281-287, 2019 Apr 14.
Artículo
en Zh
| MEDLINE | ID: mdl-31104438
20.
[Fertility and disease outcomes in patients with chronic myeloid leukemia].
Zhonghua Xue Ye Xue Za Zhi;
40(12): 980-985, 2019 Dec 14.
Artículo
en Zh
| MEDLINE | ID: mdl-32023726